• Offer of up to 8,888,889 Shares at A$0.225 per Share
• 4,444,444 free-attaching New Options to Eligible Shareholders
• Aims to raise up to A$2,000,000 before costs

Lumos Diagnostics Holdings Ltd has announced a prospectus offering, primarily for the offer of up to 8,888,889 Shares at an issue price of A$0.225 per Share and 4,444,444 free-attaching New Options to Eligible Shareholders, on the basis of one (1) free-attaching New Option for every two (2) Shares subscribed for and issued under the SPP, to raise up to A$2,000,000 (before costs). The prospectus is also being issued for the Placement Options Offer, where participants in the Placement will receive one (1) free attaching New Option for every two (2) Placement Shares subscribed for and issued. The Company is unable to rely on the ASIC Corporations (Share and Interest Purchase Plans) Instrument 2019/547 for the New Options under the SPP Offer, as the relief only relates to offers of fully paid ordinary shares. Therefore, the Company is undertaking the SPP Offer pursuant to this prospectus. The purpose of the prospectus is to make the Offers with disclosure under Part 6D of the Corporations Act and enable the on-sale of the Shares issued pursuant to the SPP Offer, as well as ensure that the on-sale of the Shares issued on conversion of the New Options do not breach section 707(3) of the Corporations Act.